Roic AI
Solutions
API Docs
MCP
Pricing
Discord
Resources
Toggle navigation menu
Company Search
⌘
K
Toggle theme
Toggle theme
Login
Sign up
Suven Pharmaceuticals Limited
N
NSE:SUVENPHAR
National Stock Exchange of India
- -
INR
- -
- -
110.56
P/E
Suven Pharmaceuticals Limited
NSE:SUVENPHAR
(National Stock Exchange of India)
Recent
price
- -
P/E
ratio
110.56
div
yld
- -
ROIC.AI
2019
2020
2021
2022
2023
2024
2025
TTM
INR
14.52
32.1
39.1
51.34
52.29
41.31
47.58
47.13
Revenue per Share
4.29
12.45
14.23
17.83
16.16
11.8
10.52
10.41
Basic EPS, GAAP
-0.25
11.94
10.67
10.01
6.73
13.08
5.26
- -
Free Cash Flow per Basic Share
0.9
3.01
1
4
8
- -
- -
- -
Dividend per Share
15.86
24.68
37.79
51
58.56
70.36
1.01
1
Book Value per Share
23.08
33.07
46.28
59.9
65.72
78.15
44.57
44.14
Tangible Book Value per Share
255
255
255
255
255
254
252
254
Basic Weighted Avg Shares
3,696
8,173
9,955
13,070
13,311
10,514
11,976
11,976
Sales/Revenue/Turnover
44.1
44.22
41.32
41.56
39.54
33.41
24.86
24.86
Operating Margin (%)
115
237
312
383
465
546
775
775
Depreciation Expense
1,093
3,170
3,623
4,538
4,113
3,003
2,648
2,645
Net Income, GAAP
30.78
21.63
22.52
32.02
26.52
25.98
23.01
23.01
Effective Tax Rate (%)
29.57
38.79
36.4
34.72
30.9
28.56
22.11
22.09
Profit Margin (%)
2,321
1,913
3,450
9,176
8,523
11,563
5,234
5,234
Working Capital
- -
918
363
289
53
212
1,757
1,757
LT Debt
5,903
8,448
11,808
15,272
17,352
20,507
18,406
18,406
Total Equity
- -
33.14
27.01
25.02
22.52
13.26
10.82
10.82
Return on Invested Capital (%)
- -
51.14
38.49
36.64
28.46
17.9
23.81
23.75
Return on Capital (%)
- -
61.44
45.57
40.16
29.5
18.3
29.16
29.13
Return on Common Equity (%)
Capital Structure
INR
•
in mil. unless spec.
Sep'25
Dec'25
Mar'25
ST Debt
88
- -
1,033
LT Borrowings
71
- -
62
LT Finance Leases
235
- -
1,695
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
255
- -
255
Market Capitalization
298,001
289,360
292,473
Working Capital
INR
•
in mil. unless spec.
Sep'25
Dec'25
Mar'25
Total Current Assets
11,677
- -
8,886
Cash, Cash Equivalents & STI
6,730
- -
2,904
Accounts Receivable, Net
1,840
- -
2,844
Inventories
2,155
- -
1,666
Total Current Liabilities
2,381
- -
3,652
Payables & Accruals
- -
- -
- -
ST Debt
88
- -
1,033
Deferred Revenue
- -
- -
- -
Growth Rates
INR
•
in mil. unless spec.
(avg. rate of change)
10 years
5 years
1 year
Total Equity
- -
18.13%
-10.24%
Free Cash Flow
- -
-3.09%
-60.21%
Net Income, GAAP
- -
-1.73%
-11.83%
Sales/Revenue/Turnover
- -
9.57%
13.91%
Total Cash Common Dividend
- -
- -
- -
Quarterly Revenue
INR
•
in mil. unless spec.
Year
Q1
Q2
Q3
Q4
FY
2023
3,388
2,784
3,538
3,601
13,311
2024
3,476
2,311
2,198
2,374
10,514
2025
2,307
2,577
3,072
4,020
11,976
Quarterly Earnings Per Share
INR
•
in mil. unless spec.
Year
Q1
Q2
Q3
Q4
FY
2023
4.22
2.83
4.23
- -
16.16
2024
4.74
3.12
1.84
- -
11.8
2025
2.39
3.23
3.26
- -
10.52
Quarterly Dividends Per Share
INR
•
in mil. unless spec.
Year
Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
8
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Similar Companies
Business
Toronto
London
Frankfurt
Dubai
Mumbai
Hong Kong
Seoul
Tokyo
Unlock non-US companies
Get Access
Already premium?
Sign in
Summary
Financials
Ratios
Charts
Classic View
Statistics
Stock Splits
Legends:
Stock price
Beta (1.0 Market)
% total return 10/25
Stock
S&P 500
1Y
- -
13.14
3Y
- -
80.78
5Y
- -
67.74